3SBio (HK:1530) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
3SBio’s subsidiary, Zhejiang Sunshine Mandi Pharmaceutical, achieved remarkable success during the 2024 ‘Double 11’ sales campaign. Its Mandi® brand topped multiple online platforms, including Tmall, JD Pharmacy, and TikTok Shop, in various OTC categories. This achievement highlights the brand’s strong market presence and potential growth in the pharmaceutical sector.
For further insights into HK:1530 stock, check out TipRanks’ Stock Analysis page.